FDA places partial hold on Curis cancer drug after patient death in clinical trial April 4, 2022 Auto Bot BioPharma, biopharma nl, cancer, clinical hold, Clinical Trial, FDA, Legal, leukemia, Lexington, Massachusetts, Pharma 0 The FDA placed a partial hold on a Curis drug in development for treating leukemia after a patient treated in a clinical trial died. The biotech company said the patient experienced a complication that is a known risk of the small molecule drug.